BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32323771)

  • 1. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
    Yang B; Liu Y; Li L; Deng H; Xian L
    Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.
    Song J; Zhang P; Liu M; Xie M; Gao Z; Wang X; Wang T; Yin J; Liu R
    DNA Cell Biol; 2019 Feb; 38(2):151-161. PubMed ID: 30526004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
    Gu JF; Liu SG; Pan Q; Qin F; Li YY
    Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 12. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN.
    Zhang N; Liu JF
    Bioengineered; 2020 Dec; 11(1):972-983. PubMed ID: 32970954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
    Wang Q; Zhang Q; Sun H; Tang W; Yang L; Xu Z; Liu Z; Jin H; Cao X
    Dig Dis Sci; 2019 Mar; 64(3):751-758. PubMed ID: 30519852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.
    Sun T; An Q; Yan R; Li K; Zhu K; Dang C; Yuan D
    Oncol Rep; 2020 Nov; 44(5):1971-1984. PubMed ID: 32901882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling.
    Ren Y; Guo T; Xu J; Liu Y; Huang J
    Pathol Res Pract; 2021 Jan; 217():153289. PubMed ID: 33248356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
    Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
    Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.
    Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.